Spectrum of hematological changes in COVID-19

Area of Science:

• Hematology
• Virology
• Immunology

Background:

• COVID-19, caused by SARS-CoV-2, rapidly became a global pandemic.
• The virus primarily affects the respiratory system but also impacts the hematopoietic system and homeostasis.
• Spike protein mediates viral entry and pathogenesis.

Purpose of the Study:

• To review hematological changes in COVID-19 patients, including blood counts, coagulation, peripheral blood, and bone marrow.
• To discuss immune profiling of B and T cell populations in relation to disease severity.
• To highlight the role of laboratory findings in early diagnosis, prognosis, and management.

Main Methods:

• Literature review of hematological and immunological changes in COVID-19.
• Analysis of blood counts, coagulation parameters, peripheral blood morphology, and bone marrow findings.
• Immune profiling of B and T cell populations correlated with clinical data.

Main Results:

• Lymphopenia is the most common laboratory finding in COVID-19.
• Coagulopathy is associated with increased morbidity and mortality.
• Severe cases may show histiocytic proliferation with hemophagocytosis in bone marrow aspirates.
• Immune profiling reveals correlations between immune responses and disease severity.

Conclusions:

• Hematological abnormalities are crucial for understanding COVID-19 pathogenesis.
• Laboratory findings aid in risk stratification, early intervention, and disease suspicion.
• Comprehensive understanding of blood count and morphological changes supports prompt diagnosis and management.